LENSAR, Inc. (LNSR) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1234968,
    "name": "LENSAR, Inc.",
    "stock_name": "LENSAR, Inc.",
    "full_name": "LENSAR, Inc.",
    "name_url": "stocks-analysis/lensar-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "11.39",
    "chg": 1.12,
    "chgp": "10.91%",
    "dir": 1,
    "prev_price": "10.27",
    "mcapval": "147.28",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US52634L1089",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "216.88 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lensar-inc-1234968-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "LENSAR, Inc. Forms Death Cross, Signaling Potential Bearish Trend Ahead",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lensar-inc-forms-death-cross-signaling-potential-bearish-trend-ahead-3619687",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/LENSARInc_dealthcross_3619687.png",
        "date": "2025-10-14 15:31:22",
        "description": "LENSAR, Inc. has recently encountered a Death Cross, indicating a potential shift in market sentiment. While the stock has performed well over the past year, recent weekly and monthly declines suggest a slowdown. Investors are advised to monitor the stock closely amid mixed technical signals and potential volatility."
      },
      {
        "title": "Is LENSAR, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lensar-inc-technically-bullish-or-bearish-3546382",
        "imagepath": "",
        "date": "2025-09-20 19:31:12",
        "description": "As of 12 September 2025, the technical trend for LENSAR, Inc. has changed from sideways to mildly bullish. The current stance is mildly bullish, driven by daily moving averages indicating mild bullishness, while the weekly MACD and KST are bearish, contrasting with the monthly indicators which are bullish. The RSI shows no signal on the weekly and is bearish on the monthly, while Bollinger Bands reflect a bearish stance weekly but bullish monthly. Dow Theory indicates a mildly bullish trend weekly but mildly bearish monthly. \n\nIn terms of performance, LENSAR has outperformed the S&P 500 significantly over the 1Y period with a return of 195.24% compared to 17.14%, and also shows strong YTD performance at 38.7% versus 12.22%...."
      },
      {
        "title": "Is LENSAR, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lensar-inc-overvalued-or-undervalued-3542966",
        "imagepath": "",
        "date": "2025-09-20 18:07:19",
        "description": "As of 9 November 2020, LENSAR, Inc. has moved from a \"does not qualify\" grade to \"risky.\" The company appears to be overvalued given its negative valuation metrics, including a Price to Book Value of -18.68 and an EV to EBITDA of -22.68. Additionally, its P/E ratio is not applicable due to the company being loss-making, which further complicates its valuation.\n\nIn comparison to its peers, LENSAR's EV to EBITDA ratio of -12.34 is significantly worse than Neuronetics, Inc. at -7.61 and electroCore, Inc. at -2.55, indicating a more pronounced risk in its valuation. Despite the overvaluation, LENSAR has shown strong recent performance, with a year-to-date return of 38.7%, significantly outperforming the S&P 500's 12.22% return. However, the overall financial health and valuation metrics suggest caution for potential investors...."
      }
    ],
    "total": 7,
    "sid": "1234968",
    "stock_news_url": "https://www.marketsmojo.com/news/lensar-inc-1234968"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

LENSAR, Inc. Forms Death Cross, Signaling Potential Bearish Trend Ahead

2025-10-14 15:31:22

LENSAR, Inc. has recently encountered a Death Cross, indicating a potential shift in market sentiment. While the stock has performed well over the past year, recent weekly and monthly declines suggest a slowdown. Investors are advised to monitor the stock closely amid mixed technical signals and potential volatility.

Is LENSAR, Inc. technically bullish or bearish?

2025-09-20 19:31:12

As of 12 September 2025, the technical trend for LENSAR, Inc. has changed from sideways to mildly bullish. The current stance is mildly bullish, driven by daily moving averages indicating mild bullishness, while the weekly MACD and KST are bearish, contrasting with the monthly indicators which are bullish. The RSI shows no signal on the weekly and is bearish on the monthly, while Bollinger Bands reflect a bearish stance weekly but bullish monthly. Dow Theory indicates a mildly bullish trend weekly but mildly bearish monthly. In terms of performance, LENSAR has outperformed the S&P 500 significantly over the 1Y period with a return of 195.24% compared to 17.14%, and also shows strong YTD performance at 38.7% versus 12.22%....

Is LENSAR, Inc. overvalued or undervalued?

2025-09-20 18:07:19

As of 9 November 2020, LENSAR, Inc. has moved from a "does not qualify" grade to "risky." The company appears to be overvalued given its negative valuation metrics, including a Price to Book Value of -18.68 and an EV to EBITDA of -22.68. Additionally, its P/E ratio is not applicable due to the company being loss-making, which further complicates its valuation. In comparison to its peers, LENSAR's EV to EBITDA ratio of -12.34 is significantly worse than Neuronetics, Inc. at -7.61 and electroCore, Inc. at -2.55, indicating a more pronounced risk in its valuation. Despite the overvaluation, LENSAR has shown strong recent performance, with a year-to-date return of 38.7%, significantly outperforming the S&P 500's 12.22% return. However, the overall financial health and valuation metrics suggest caution for potential investors....

View All News